Application of Nanomaterial-Mediated Ferroptosis Regulation in Kidney Disease
International Journal of Nanomedicine · 2025
DOI: 10.2147/ijn.s496644 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Nanomedicine, 2025. Verfasst von Jiamin Zhu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Heilongjiang Key Laboratory of Anti-Fibrosis Biotherapy, Mudanjiang Medical University, Mudanjiang, People's Republic of China. Hauptthemen laut MEDLINE: Ferroptosis, Nanostructures, Kidney Diseases. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 133 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Heilongjiang Key Laboratory of Anti-Fibrosis Biotherapy, Mudanjiang Medical University, Mudanjiang, People's Republic of China.
- School of First Clinical Medical College, Mudanjiang Medical University, Mudanjiang, People's Republic of China.
ORCID-Profile: Luxin Li
Zitieren
APA
Zhu, J., Zhang, Z., Chu, Y., Xie, Z., Zeng, D., Jin, L., & Li, L. (2025). Application of Nanomaterial-Mediated Ferroptosis Regulation in Kidney Disease. International Journal of Nanomedicine. https://doi.org/10.2147/ijn.s496644
Vancouver
Zhu J, Zhang Z, Chu Y, Xie Z, Zeng D, Jin L, et al. Application of Nanomaterial-Mediated Ferroptosis Regulation in Kidney Disease. International Journal of Nanomedicine. 2025. doi:10.2147/ijn.s496644
BibTeX
@article{Zhu2025,
author = {Zhu, Jiamin and Zhang, Zhen and Chu, Yanhui and Xie, Zhongyin and Zeng, Dongmei and Jin, Lijiao and Li, Luxin},
title = {Application of Nanomaterial-Mediated Ferroptosis Regulation in Kidney Disease},
journal = {International Journal of Nanomedicine},
year = {2025},
doi = {10.2147/ijn.s496644}
}
EUVIMED